## Abstract Iptakalim hydrochloride (__N__‐(1‐methylethyl)‐1,1,2‐trimethyl‐propylamine hydrochloride) is a promising antihypertensive drug discovered and developed by Beijing Institute of Pharmacology and Toxicology. Deuterium‐ and tritium‐labelled compounds were designed and synthesized for pharma
Synthesis of [1,2-3H]ethylamine hydrochloride and [3H]-labeled apadenoson for a human ADME study
✍ Scribed by Yang Hong; Samuel J. Bonacorsi Jr; Yuan Tian; Sharon Gong; Donglu Zhang; W. Griffith Humphreys; Balu Balasubramanian; Edward H. Cheesman; Zhiqin Zhang; James F. Castner; Paul D. Crane
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- French
- Weight
- 189 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Tritium‐labeled [1,2‐^3^H]ethylamine hydrochloride was prepared through a multiple‐step sequence in high radioactive specificity. The labeled amine was isolated in high purity following cartridge filtration and used subsequently in the synthesis of [N‐ethyl‐1,2‐^3^H]apadenoson, an adenosine A~2a~ receptor agonist. The overall yield for this transformation was 56% and the radiochemical purity of the final product was greater than 99%. Copyright © 2008 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract A synthetic route to isotopically labelled forms of the tropane alkaloid hyoscyamine, including (__RS__)‐[3′, 3′,‐^2^H~2~]‐ (**2a**) and (__RS__)‐[1′‐^13^C, 3′, 3′,‐^2^H~2~]‐ (**2b**) hyoscyamines, involving the reaction between phenylacetyl tropine and formaldehyde is described. The is